Literature DB >> 11408755

Hormonal control of growth hormone secretion.

M Pombo1, C M Pombo, A Garcia, E Caminos, O Gualillo, C V Alvarez, F F Casanueva, C Dieguez.   

Abstract

Growth hormone secretion by the somatotroph cells depends upon the interaction between hypothalamic regulatory peptides, target gland hormones and a variety of growth factors acting in a paracrine or autocrine fashion. This review will be focused on recent data regarding the mechanism by which growth hormone-releasing hormone (GHRH) influences somatotroph cell function and the physiological role played by Ghrelin and leptin in the regulation of growth hormone (GH) secretion. It is well established that binding of GHRH to its receptor leads to activation of protein kinase A (PKA). More recently, it was found that GHRH can also activate mitogen-activated protein (MAP) kinase both in pituitary cells and in a cell line overexpressing the GHRH receptor. Whether somatotroph adenomas, either with or without a GS-alpha mutation, have alterations in some of the components of the activation of the MAP kinase pathway remains to be known. The recent isolation of Ghrelin, the endogenous ligand of the growth hormone secretagogue receptor, can be considered a landmark in the GH field, which opens up the possibility of gaining greater insight into our understanding of the mechanisms involved in the regulation of GH secretion and somatic growth. Indeed, preliminary evidences indicate that this peptide exerts a marked stimulatory effect on plasma GH levels in both rats and humans. Finally, it is well known that GH secretion is markedly influenced by nutritional status. Leptin has emerged as an important adipose tissue-generated signal that is involved in the regulation of GH secretion, thus providing an integrated regulatory system of growth and metabolism. Although the effects of leptin on GH secretion in humans remain to be clarified, indirect evidences indicate that it may play an inhibitory role. Copyright 2001 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11408755     DOI: 10.1159/000063456

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  10 in total

1.  The negative association between plasma ghrelin and IGF-I is modified by obesity, insulin resistance and type 2 diabetes.

Authors:  S M Pöykkö; O Ukkola; H Kauma; E Kellokoski; S Hörkkö; Y A Kesäniemi
Journal:  Diabetologia       Date:  2005-02-02       Impact factor: 10.122

Review 2.  Leptin in human physiology and pathophysiology.

Authors:  Christos S Mantzoros; Faidon Magkos; Mary Brinkoetter; Elizabeth Sienkiewicz; Tina A Dardeno; Sang-Yong Kim; Ole-Petter R Hamnvik; Anastasia Koniaris
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-07-26       Impact factor: 4.310

Review 3.  Leptin in human physiology and therapeutics.

Authors:  Tina A Dardeno; Sharon H Chou; Hyun-Seuk Moon; John P Chamberland; Christina G Fiorenza; Christos S Mantzoros
Journal:  Front Neuroendocrinol       Date:  2010-06-17       Impact factor: 8.606

Review 4.  Growth hormone resistance in uremia, a role for impaired JAK/STAT signaling.

Authors:  Ralph Rabkin; Di Fei Sun; Yu Chen; Jane Tan; Franz Schaefer
Journal:  Pediatr Nephrol       Date:  2005-02-04       Impact factor: 3.714

5.  The relationship between serum ghrelin levels and hair zinc concentrations in children.

Authors:  Nihal Hatipoğlu; Mehmet Emre Atabek; Selim Kurtoğlu; Esad Köklü
Journal:  J Clin Res Pediatr Endocrinol       Date:  2008-08-01

Review 6.  Growth hormone axis in chronic kidney disease.

Authors:  Shefali Mahesh; Frederick Kaskel
Journal:  Pediatr Nephrol       Date:  2007-08-05       Impact factor: 3.714

7.  The effects of growth hormone on therapy resistance in cancer.

Authors:  Reetobrata Basu; John J Kopchick
Journal:  Cancer Drug Resist       Date:  2019-09-19

8.  GHR is involved in gastric cell growth and apoptosis via PI3K/AKT signalling.

Authors:  Hong-Zhu Yan; Hua-Feng Wang; Yueling Yin; Jue Zou; Feng Xiao; Li-Na Yi; Ying He; Bo-Sheng He
Journal:  J Cell Mol Med       Date:  2021-01-25       Impact factor: 5.310

9.  The effect of enteral and parenteral feeding on secretion of orexigenic peptides in infants.

Authors:  Przemyslaw J Tomasik; Krystyna Sztefko
Journal:  BMC Gastroenterol       Date:  2009-12-10       Impact factor: 3.067

Review 10.  Dual Characters of GH-IGF1 Signaling Pathways in Radiotherapy and Post-radiotherapy Repair of Cancers.

Authors:  Yunyun Cheng; Wanqiao Li; Ruirui Gui; Chunli Wang; Jie Song; Zhaoguo Wang; Xue Wang; Yannan Shen; Zhicheng Wang; Linlin Hao
Journal:  Front Cell Dev Biol       Date:  2021-06-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.